As of 2025-03-20, the EV/EBITDA ratio of Clearpoint Neuro Inc (CLPT) is -18.59. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. CLPT's latest enterprise value is 349.59 mil USD. CLPT's TTM EBITDA according to its financial statements is -18.81 mil USD. Dividing these 2 quantities gives us the above CLPT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 20.7x | 19.2x |
| Forward P/E multiples | 20.8x - 21.5x | 21.2x |
| Fair Price | (13.46) - (13.36) | (13.02) |
| Upside | -200.6% - -199.9% | -197.3% |
| Date | EV/EBITDA |
| 2025-03-17 | -18.03 |
| 2025-03-14 | -17.74 |
| 2025-03-13 | -17.38 |
| 2025-03-12 | -18.30 |
| 2025-03-11 | -17.59 |
| 2025-03-10 | -16.88 |
| 2025-03-07 | -18.13 |
| 2025-03-06 | -18.31 |
| 2025-03-05 | -19.75 |
| 2025-03-04 | -18.63 |
| 2025-03-03 | -18.84 |
| 2025-02-28 | -20.26 |
| 2025-02-27 | -19.80 |
| 2025-02-26 | -24.23 |
| 2025-02-25 | -23.50 |
| 2025-02-24 | -23.00 |
| 2025-02-21 | -23.50 |
| 2025-02-20 | -24.57 |
| 2025-02-19 | -25.24 |
| 2025-02-18 | -26.30 |
| 2025-02-14 | -25.85 |
| 2025-02-13 | -25.94 |
| 2025-02-12 | -25.42 |
| 2025-02-11 | -25.02 |
| 2025-02-10 | -25.61 |
| 2025-02-07 | -25.61 |
| 2025-02-06 | -26.70 |
| 2025-02-05 | -26.55 |
| 2025-02-04 | -25.92 |
| 2025-02-03 | -23.83 |
| 2025-01-31 | -24.58 |
| 2025-01-30 | -24.80 |
| 2025-01-29 | -25.07 |
| 2025-01-28 | -25.29 |
| 2025-01-27 | -23.91 |
| 2025-01-24 | -25.16 |
| 2025-01-23 | -25.05 |
| 2025-01-22 | -25.26 |
| 2025-01-21 | -25.99 |
| 2025-01-17 | -21.03 |
| 2025-01-16 | -20.91 |
| 2025-01-15 | -21.14 |
| 2025-01-14 | -20.52 |
| 2025-01-13 | -21.56 |
| 2025-01-10 | -20.50 |
| 2025-01-08 | -21.07 |
| 2025-01-07 | -21.62 |
| 2025-01-06 | -22.07 |
| 2025-01-03 | -22.28 |
| 2025-01-02 | -21.76 |